185 funds take the wrong medicine to hit the new medicine stock floating loss billion

Securities Times reporter Yu Zijun the medical unit suffered black June. Since June 11 to the close yesterday, according to the SFC industry classification of the pharmaceutical sector as a whole fell 16.59%, the same time all the plate decline, the same period, the Shanghai index declined only 5.29%. Affected by the overall weakness of the pharmaceutical sector, the listing of 9 in the pharmaceutical industry since April, 5 of new shares have fallen below the IPO price, accounted for more than half.　　A total of 185 funds to participate in the above 5 new shares under the network placement and was deeply set therein, the cumulative floating loss of more than 100 million yuan. Days of congenial data statistics show that since April, the total issue of 9 pharmaceutical shares, calculated at yesterday's closing price, of which 5 stocks have fallen below the offer price, respectively, Hepalink, Canchi Pharmaceutical, sang pharmaceutical, Pibao Pharmaceutical and Hansen Pharmaceutical, respectively, compared to the IPO price down 18.91%, 13.85%, 9.07%, 8.25　　% and 7.49%. As a result of the network under the placing of new shares 3-month lock-up period, the above-mentioned funds under the Network Placement Unit is still locked.　　From the above 5 stocks under the net placing results, a total of 185 funds to participate in 5 new shares under the network placement, the cumulative 8.0744 million shares, with yesterday's closing price calculation, floating loss has reached 105 million yuan. Specifically, the Fund to participate in the highest enthusiasm for the sea, the quilt is also the deepest, a total of 80 funds to participate in the shares under the net placing, the cumulative 2.8446 million shares.　　The shares yesterday's closing price of 120.02 yuan, compared to the offering price of 148 yuan fell 18.91%, floating deficit of 79.5911 million yuan.　　In addition, the participation of the Canchi Pharmaceutical network under the allocation of funds currently floating deficit also more than tens of millions of dollars, a total of 30 funds to participate in the shares under the net placement, the cumulative 1.5576 million shares, the shares yesterday's closing price of 51.69 yuan, compared to the price of 60 yuan down 13.85%, the cumulative floating Compared to the 2 pharmaceutical stocks, 3 other pharmaceutical stocks have less floating losses. Of these, 26 funds were involved in placing the Sang pharmaceutical network,　　The cumulative 1.805 million shares, according to yesterday's closing price calculation, the fund floating deficit of 7.3644 million yuan, a total of 11 funds to participate in Pi Bao Pharmaceutical network placing, the cumulative 818,600 shares, floating loss of 2.0137 million yuan; a total of 38 funds to participate in the Han Sen Pharmaceutical Network placing, the cumulative share of 1.0487 million shares, floating loss of 2.8104 million yuan.　　Fund industry insiders said there are two reasons for the medical unit break, on the one hand, by the pharmaceutical sector since the middle of June has continued to weaken the drag, on the other hand, because the agency 2009 relatively optimistic about the pharmaceutical stocks, leading to the pharmaceutical industry, the overall issue of the new shares on the high price, some of the pharmaceutical stocks 5 Break medicine Stock Fund floating loss list name first price (yuan) June 29 close (yuan) compared to the issue of the offer rate (%), the fund was awarded a total number of funds (million) floating loss (million) Hepalink 148120. 02 18. 9180 284. 46 7959.11 Canchi Pharmaceutical Industry 60 51. 6913. 8530 155. 76 1294. 33 sang pharmaceutical 45 40. 929. 07 26 180. 5 736. 44 Leather Bao Pharmaceutical 29. 8227. 368. 25 11 81. 86 201. 37 Han Sen pharmaceutical 35. 8 33. 127. 49 38 104. 87 281. 04 Watchmaker: Yu Zijun